Literature DB >> 27501769

Is there room for bevacizumab in metastatic breast cancer?

Adam Brufsky1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27501769     DOI： 10.1016/S1470-2045(16)30295-9

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

Review 1.  Insights into the success and failure of systemic therapy for hepatocellular carcinoma.

Authors:  Jordi Bruix; Leonardo G da Fonseca; María Reig
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-08-01       Impact factor: 46.802

2.  A randomized, double-blind, single-dose study to evaluate the biosimilarity of QL1101 with bevacizumab in healthy male subjects.

Authors:  Ya-Nan Liu; Jie Huang; Can Guo; Shuang Yang; Ling Ye; Shu-Ting Wu; Xing-Fei Zhang; Xiao-Yan Yang; Cui-Cui Han; Qi Pei; Lu Huang; Qing-Nan He; Guo-Ping Yang
Journal:  Cancer Chemother Pharmacol       Date:  2020-01-06       Impact factor: 3.333
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.